课题基金 / 基金详情

Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection

Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection
新型 VP30 与宿主相互作用可负调节埃博拉病毒感染
批准号:
10721290
负责人:
Gaya K. Amarasinghe
金额:
$6.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-03-01 至 2025-02-28

项目摘要

项目成果

Gaya K. Amarasinghe的其他基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
Project Summary/Abstract The filoviruses, Ebola and Marburg viruses (EBOV and MARV), are emerging, negative-strand RNA viruses associated with outbreaks of severe viral hemorrhagic fever. The virulence and emerging nature of these zoonotic pathogens makes them a significant threat to human health, potential agents of bioterrorism, and NIAID category A priority pathogens. The overall goal of the parent R01 application is to characterize EBOV VP30 (eVP30), a key viral protein that facilitates viral transcription, and its interactions with host factors. This supplement request in response to PA-21-071 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) will support the training and career development of trainee currently enrolled in a medical student training program to develop her career as a physician scientist. Scientific research program, which extends protein-protein interaction and post translational modification studies will map the ubiquitination of filoviral proteins. These proposed efforts will enhance our understanding of filoviral-host interactions and provide an opportunity for career development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses
  • 批准号:
    10667857
  • 项目类别:
  • 资助金额:
    $78.36万
  • 财政年份:
    2023
  • 负责人:
    Gaya K. Amarasinghe
  • 依托单位:
HSP90 paralog selective small molecules as anti-old-world alpha-viral therapeutic leads.
  • 批准号:
    10753347
  • 项目类别:
  • 资助金额:
    $24.77万
  • 财政年份:
    2023
  • 负责人:
    Gaya K. Amarasinghe
  • 依托单位:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
  • 批准号:
    10481430
  • 项目类别:
  • 资助金额:
    $29.65万
  • 财政年份:
    2022
  • 负责人:
    Gaya K. Amarasinghe
  • 依托单位:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
  • 批准号:
    10683329
  • 项目类别:
  • 资助金额:
    $27.21万
  • 财政年份:
    2022
  • 负责人:
    Gaya K. Amarasinghe
  • 依托单位: